阿伦德罗纳特功能化向骨的莫酸脂质体 恢复骨平衡 治疗骨质疏松症
Demeng Xia1,2, Qingqing Qian1, Sheng Wang3
1Department of Pharmacy, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, 200240, People's Republic of China.
International journal of nanomedicine
|August 13, 2024
概括
一种针对骨的新型纳米药物有效地提供 pomolic 酸 (PA) 来治疗骨质疏松症. 与传统方法相比,这种有针对性的方法提高了骨愈合,减少了系统性毒性,为骨损失提供了有前途的新疗法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症,以不平衡的骨吸收和形成为标志,构成严重的健康风险,特别是在老年人群中.
- 目前针对骨质疏松症的治疗方法有限,这凸显了对创新的药物开发和输送系统的需求.
研究的目的:
- 开发一种用于骨质疏松症治疗的新型骨向纳米药物.
- 为了提高pomol酸 (PA) 的溶解性和向性,以提高治疗效果.
主要方法:
- 合成和净化PA@TLipo,一种纳米药物,将pomlic acid (PA) 封装在alendronate功能化的脂质体内.
- 使用体外和体外模型评估PA@TLipo的细胞毒性,向骨和抗骨质疏松作用.
主要成果:
- PA@TLipo证明了对骨组织的增强聚合,减少骨损失和全身细胞毒性.
- 在实验室中,纳米药物有效地抑制了骨质细胞的形成和骨的再吸收.
- 在卵巢切除诱导的骨质疏松症小鼠中观察到骨质损失的显著减少.
结论:
- 开发了一种针对骨的新型输送系统,用于治疗骨质疏松症.
- PA@TLipo通过改善药物向性和减少副作用,为骨质疏松症提供了一个创新的解决方案.
- 这项研究代表了首次使用骨向输送系统的PA在管理OVX诱导的骨损失.
相关概念视频
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Essential Minerals for Bone Health
3.8K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
3.8K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K


